Stock Levels: Gsk Spokesperson and Shortage List

stock levels: In April, international supplier Glaxo Smith Kline added their Measles Mumps Rubella vaccine Priorix and their Measles Mumps Rubella and Varicella vaccine Priorix Tetra to the TGA's critical shortage list with current stock levels across the globe anticipated to last until October, according to Nine News Australia. This only impacts our supply to the private market, A GSK spokesperson told 9news.au. To improve your experience update it here News Health Global measles vaccine shortage causes concern locally By Tom Livingstone Associate Producer3 19pm May 10, are concerns of a measles vaccination shortage after one of two major suppliers logged their supply levels as critical with Australia's Therapeutic Goods Administration. Despite a major supplier of the Measles, Mumps and Rubella vaccine logging levels as critical, they say child immunisations will take priority. This shortage will impact our ability to supply Priorix Tetra to the National Immunisation Program NIP but we have worked with the Commonwealth Department of Health to ensure that an alternative MMRV vaccine will be available during this time, the GSK spokesperson said. EPA They confirmed that they were not the only supplier of MMR vaccines and that they have sourced an alternative to control the rising issue. (news.financializer.com). As reported in the news.